Fang Yao

机构：Chinese Center For Disease Control and Prevention, Chinese Academy of Medical Sciences & Peking Union Medical College, Endocrine Society, Shenzhen Institutes of Advanced Technology, Fu Wai Hospital · ORCID：0000-0002-3640-6139

发表论文 111 篇 · 总被引 2054 次 · h-index 28

代表论文

• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 77)
• Serpina3k lactylation protects from cardiac ischemia reperfusion injury (2025 · Nature Communications · 被引 55)
• FOXO3a-regulated arginine metabolic plasticity adaptively promotes esophageal cancer proliferation and metastasis (2023 · Oncogene · 被引 14)
• Runx2-NLRP3 axis orchestrates matrix stiffness-evoked vascular smooth muscle cell inflammation (2025 · American Journal of Physiology-Cell Physiology · 被引 10)
• The advance of single cell transcriptome to study kidney immune cells in diabetic kidney disease (2024 · BMC Nephrology · 被引 9)
• Association of Ambient Temperature and Relative Humidity With Respiratory Syncytial Virus Infections Among Hospitalized Children in Suzhou, Eastern China: A Time‐Series Analysis (2025 · GeoHealth · 被引 6)